Bio-Techne Corp
(NAS:TECH)
$
73.31
-1.88 (-2.5%)
Market Cap: 11.65 Bil
Enterprise Value: 11.86 Bil
PE Ratio: 77.99
PB Ratio: 5.45
GF Score: 94/100 Bio-Techne Corp at Credit Suisse Healthcare Conference Transcript
Nov 09, 2022 / 04:35PM GMT
Release Date Price:
$78.27
(+0.86%)
Daniel Louis Leonard;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
All right. Greenlight means [re-life]. Our next session is Bio-Techne. We're lucky to have with us CEO of Bio-Techne, Chuck Kummeth. I'm Dan Leonard, I'm the life science tools analyst at Credit Suisse. Welcome, Chuck.
Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director
Glad to be here, Dan.
Questions & Answers
Daniel Louis Leonard;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
Thanks for coming. You just reported your quarter a week ago. So I thought a good way to start-off the fireside chat would be to highlight key takeaways from your September quarter results.
Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director
Sure. Well, the first thing is here it was, missed top line, I wouldn't say bottom line, but first missed ten or 11 quarters or so. But we kind of talked about that
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot